Siemens Healthineers (SHL) Given Neutral Rating at DZ Bank

DZ Bank reaffirmed their neutral rating on shares of Siemens Healthineers (ETR:SHL) in a report published on Monday morning.

SHL has been the topic of several other reports. Royal Bank of Canada set a €37.00 ($43.02) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Monday. Sanford C. Bernstein set a €41.00 ($47.67) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Monday. JPMorgan Chase & Co. set a €36.90 ($42.91) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Tuesday, July 24th. Citigroup set a €42.50 ($49.42) price target on shares of Siemens Healthineers and gave the stock a buy rating in a research report on Thursday, September 27th. Finally, equinet set a €39.00 ($45.35) price target on shares of Siemens Healthineers and gave the stock a neutral rating in a research report on Monday, July 30th. Fourteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of €38.37 ($44.61).

ETR SHL opened at €38.66 ($44.95) on Monday.

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Featured Article: What factors cause inflation to rise?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply